Companies in the genetics sector developing innovative solutions and technologies.
Explore 345 recently funded genetics companies with verified founder contact information and fundraising data.
Connexus Therapeutics is a private, venture-backed biotechnology startup.
Alvara Therapeutics develops small-molecule therapies for chronic kidney disease.
Flomics mines the nucleic acids in your fluids to create affordable, non-invasive and accurate diagnostics
Clinical decision support platform for pharmacogenomics, medication safety, and real-world evidence.
Ubiquitome offers genomic information solutions with portable cloud-connected genetic analysis devices.
Helogen Corporation is a space biology and infrastructure company specializing in autonomous orbital laboratories for biomanufacturing.
HAYA Therapeutics is a biotechnology company developing precision RNA-guided medicines that target the dark genome.
WhiteLab Genomics develops digital tools that help gene and cell therapy companies develop cheaper drugs faster.
Tailwind Biotech offers AI-powered synthetic DNA design services for biomanufacturing companies.
Poseida Therapeutics is a biopharmaceutical company utilizing gene engineering capabilities to develop targeted therapeutics.
Layka Bio is a biotechnology company that offers genetic research, bioinformatics, and precise lab testing for better health.
Mission Bio develops only single-cell multi-omics platform integrating genotype and phenotype for cancer research and biomarker development.
The Hospital Immune System. Built to stop outbreaks before they start.
Amber Bio is a biotechnology company pioneering new gene editing modalities using multi-kilobase edits.
Algen Biotechnologies is a therapeutic discovery company that builds a platform to decode functional gene networks.
Fermelanta is a biotech firm that produces rare plant-based ingredients through microbial fermentation.
Nygen Analytics offers cloud-based solutions for sustainable and cost-effective analysis of single-cell genomic data.
Molecular Assemblies is developing a revolutionary, enzymatic DNA synthesis technology capable of powering new products.
Codebreaker Labs builds causal genomics data by experimentally mapping genetic variants to cellular effects, powering AI for medicine.
Polaris Genomics identifies genomic biomarkers to support the development of psychiatric drugs and clinical tools.
Revier Therapeutics develops small-molecule therapies for cardiometabolic diseases.
TeselaGen Biotechnology develops DNA design and assembly tools for biology.
ID Genomics specializes in nucleotide sequence-based molecular diagnostics and epidemiologic analysis of microbial pathogens.
GATC Health uses AI to speed drug discovery, predict outcomes, and support research with data-driven healthcare insights.
SynaptixBio is a biotechnology research company that develops lifesaving therapies for severe leukodystrophies.
The genetics sector is an active area of startup innovation and venture capital investment. Companies in this space are developing new technologies, platforms, and services that address evolving market needs and create new business opportunities.
Genetics companies raise capital across various funding stages, from early seed rounds to late-stage growth financing. Investor interest in this sector is driven by the size of the addressable market, the pace of technology adoption, and the potential for scalable business models.
The genetics sector is expected to continue evolving as technology advances, market dynamics shift, and new opportunities emerge. Companies that demonstrate strong product-market fit, efficient growth, and clear competitive advantages are well-positioned to attract continued investment.
Here is how funding is distributed among the 345 genetics companies tracked in the VCBacked database.
Companies in the genetics sector often overlap with or complement businesses in adjacent industries. Exploring related verticals can help you discover additional companies, identify partnership opportunities, and understand the broader competitive landscape.
Perfect for: B2B sales teams targeting genetics companies, investors exploring sector opportunities, and service providers looking for funded companies ready to scale.
Get Started - Access Contact InformationJoin thousands of sales teams, investors, and service providers using VCBacked